Emcure Pharma shares advance 10% as Kotak Equities sees 28% upside in stock
Driven by strong organic growth, an in-licensing agreement with Sanofi, the consolidation of Mantra, and the resolution of most legal challenges, Emcure is projected...
Emcure Pharma shares advance 10% as Kotak Equities sees 28% upside in stock
Driven by strong organic growth, an in-licensing agreement with Sanofi, the consolidation of Mantra, and the resolution of most legal challenges, Emcure is projected...
Emcure Pharma shares advance 10% as Kotak Equities sees 28% upside in stock
Driven by strong organic growth, an in-licensing agreement with Sanofi, the consolidation of Mantra, and the resolution of most legal challenges, Emcure is projected...
Emcure Pharma shares advance 10% as Kotak Equities sees 28% upside in stock
Driven by strong organic growth, an in-licensing agreement with Sanofi, the consolidation of Mantra, and the resolution of most legal challenges, Emcure is projected...
Gold prices continue to drop amid a strong dollar and US inflation concerns; check rates in your city
Gold prices have dropped by around 6% since Diwali, pressured by a stronger US dollar and rising inflation concerns. The price of 24-carat gold...